Romidepsin drug shows surprising benefit in preclinical studies of inflammatory breas

[News]

A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer, according to a researcher at Thomas Jefferson University's Kimmel Cancer Center.

More... (http://www.news-medical.net/news/20131211/Romidepsin-drug-shows-surprising-benefit-in-preclinical-studies-of-inflammatory-breast-cancer.aspx)